November 17, 2017 in Dilumen, Lumendi, News, Press Release, Uncategorized

LUMENDI REPORTS SUCCESSFUL COMPLETION OF DILUMEN™ EIP FIRST-IN-HUMAN TRIALS

LUMENDI REPORTS SUCCESSFUL COMPLETION OF DILUMEN™ EIP FIRST-IN-HUMAN TRIALS Primary Study Endpoint Reached with no Serious Adverse Events WESTPORT, CONNECTICUT, November 16, 2017 – Connecticut-based medical device innovator Lumendi, LLC... Read More
November 9, 2017 in Dilumen, Lumendi, News, Press Release, Uncategorized

LUMENDI’S DILUMEN Ig™ ENDOLUMENAL INTERVENTIONAL GRASPER FOR MINIMALLY INVASIVE ENDOSCOPIC THERAPIES NOW AVAILABLE IN U.S.

LUMENDI’S DILUMEN Ig™ ENDOLUMENAL INTERVENTIONAL GRASPER FOR MINIMALLY INVASIVE ENDOSCOPIC THERAPIES NOW AVAILABLE IN U.S. Lumendi Submits Premarket Notification to US FDA For DiLumen C2™ and the DiLumen Is™ as Part... Read More
October 19, 2017 in Lumendi, News, Press Release, staff, Uncategorized

LUMENDI EXPANDS MEDICAL ADVISORY BOARD WITH THREE GLOBAL EXPERTS IN ADVANCED ENDOSCOPY

LUMENDI EXPANDS MEDICAL ADVISORY BOARD WITH THREE GLOBAL EXPERTS IN ADVANCED ENDOSCOPY Dr. Sergey V. Kantsevoy, Professor Alessandro Repici and Professor Kazuki Sumiyama to help guide improvements in endoscopic interventions... Read More
October 4, 2017 in Dilumen, News, Press Release

LUMENDI EXPANDS SOCIAL MEDIA PRESENCE

LUMENDI EXPANDS SOCIAL MEDIA PRESENCE WITH NEW YOU TUBE CHANNEL DEDICATED TO ITS DILUMEN™ EIP WESTPORT, CONNECTICUT, October 4, 2017 – Lumendi, LLC (http:/lumendi.com), a wholly owned subsidiary of Lumendi,... Read More